Assenagon Asset Management »

Travere Therapeutics shares owned by Assenagon Asset Management

Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by Assenagon Asset Management from 13F filings

Historical chart of Assenagon Asset Management investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Assenagon Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Assenagon Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.7M 219k 7.71
2023-12-31 $2.3M 254k 8.99
2023-09-30 $2.3M 254k 8.94
2023-06-30 $17M 1.1M 15.36
2023-03-31 $37M 1.7M 22.49
2022-12-31 $18M 867k 21.03
2022-09-30 $23M 925k 24.64
2022-06-30 $23M 951k 24.23
2022-03-31 $8.0M 311k 25.77
2021-12-31 $6.1M 196k 31.04